VentureDeal Venture Capital Funding Quarterly Reports
MENLO PARK, CA, September 16, 2008 – Venture capital database VentureDeal is pleased to announce the release of complimentary Venture Capital Funding Quarterly transaction reports. The reports are exclusively sponsored by Bio Investor Forum, a conference featuring late stage private and emerging public companies, with a special focus on investment strategies and competitive therapeutic and drug development landscapes.
Covering the second quarter of 2008, the reports provide a combination of notable venture capital transactions, insights into trends by industry sector and aggregated data.
Written by recognized industry contributors, the current reports released for Q2 2008 may be found by clicking the links below:
-- Alternative Energy - Clean Technology - Energy - Environmental Web | PDF
-- Biotechnology - Pharmaceutical - Medical Devices Web | PDF
-- Internet - Digital Media - eCommerce - Software Web | PDF
-- Telecom - Wireless - Mobile - Communications Web | PDF
Companies such as professional service firms, technology companies and venture capital firms derive benefit from new perspectives on industry trends, discovering new companies being funded and which venture capital firms, angel groups, private equity firms and venture lenders provided the financing.
To view all reports, visit: http://www.venturedeal.com/Reports/Default.aspx.
VentureDeal is a venture capital database that provides comprehensive technology company intelligence tools to service firms, technology companies and venture investors. VentureDeal subscribers receive real-time information about U.S.-based companies being funded or acquired, along with who is involved - down to the individual decision maker, company management and venture capital firm partner.
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
1259 El Camino Real, Suite 410
Menlo Park, CA 94025